Market Place
Sourcing Support
DiscGenics FDA-Approved For Phase III Trial Of Disc Cell Therapy
16 Jul 2024 //
PR NEWSWIRE
DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
PR NEWSWIRE
Data for DiscGenics`s Progenitor Cell Therapy to Be Presented at NASS 2022
11 Oct 2022 //
PRNEWSWIRE
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa
05 Oct 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.